The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy

BACKGROUND: The application of podocyte antigen M-type phospholipase A2 receptor (PLA2R, GAg) and serum anti-PLA2R antibody (SAb) in predicting the prognosis of membrane nephropathy (MN) was controversial. METHOD: 328 biopsy-proven MN patients were divided into three phenotypes, 182 MN patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Xu, Ying, Chen, Siyu, Yu, Yedong, Zhu, Xueling, Chen, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566392/
https://www.ncbi.nlm.nih.gov/pubmed/37814415
http://dx.doi.org/10.1080/0886022X.2023.2264939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566392/
https://www.ncbi.nlm.nih.gov/pubmed/37814415
http://dx.doi.org/10.1080/0886022X.2023.2264939

Ejemplares similares